Effect of the COVID-19 Pandemic on Delayed Skin Cancer Services
- PMID: 34556252
- PMCID: PMC8162820
- DOI: 10.1016/j.det.2021.05.015
Effect of the COVID-19 Pandemic on Delayed Skin Cancer Services
Abstract
The COVID-19 pandemic has presented a unique set of challenges to cancer care centers around the world. Diagnostic and treatment delays associated with lockdown periods may be expected to increase the total number of avoidable skin cancer deaths. During this unprecedented time, dermatologists have been pressed to balance early surgical interventions for skin cancer with the risk of viral transmission. This article summarizes evidenced-based recommendations for the surgical management of cutaneous melanoma, keratinocyte cancer, and Merkel cell carcinoma during the COVID-19 pandemic. Additional long-term studies are required to determine the effect of COVID-19 on skin cancer outcomes.
Keywords: COVID-19; COVID-19 delays; Evidence-based guidelines; Skin cancer; Surgical delay; Survival; Time to surgery.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The authors have nothing to disclose.
References
-
- Meredith J.W., High K.P., Freischlag J.A. Preserving elective surgeries in the COVID-19 pandemic and the future. JAMA. 2020;324(17):1725. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
